ESR1 and systemic lupus erythematosus: JNK pathway-associated phosphatase expression has been reported to be associated with disease activity and outcome in SLE and colorectal cancer (13, 31), and it is commonly accepted that CDAI, Mayo index for UC, CRP, and ESR are important indicators for clinical disease activity in IBD patients (22–24).